Scarica l'app Stockscreener
5.87
1.43%
-0.085
Precedente Chiudi:
$5.955
Aprire:
$6.01
Volume 24 ore:
81,853
Relative Volume:
0.74
Capitalizzazione di mercato:
$297.31M
Reddito:
-
Utile/perdita netta:
$-25.50M
Rapporto P/E:
-7.6234
EPS:
-0.77
Flusso di cassa netto:
$-30.10M
1 W Prestazione:
-5.78%
1M Prestazione:
+7.71%
6M Prestazione:
+47.86%
1 anno Prestazione:
+86.35%
Intervallo 1D:
$5.85
$6.01
Intervallo di 1 settimana:
$5.72
$6.44
Portata 52W:
$2.6801
$7.19
Eupraxia Pharmaceuticals Inc Stock (EPRX) Company Profile
Nome
Eupraxia Pharmaceuticals Inc
Settore
Industria
Telefono
-
Indirizzo
-
Confronta EPRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
EPRX
Eupraxia Pharmaceuticals Inc
|
5.87 | 301.61M | 0 | -25.50M | -30.10M | -0.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Eupraxia Pharmaceuticals Inc Stock (EPRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-24 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-06-26 | Iniziato | H.C. Wainwright | Buy |
| 2025-06-16 | Iniziato | Canaccord Genuity | Speculative Buy |
| 2025-02-21 | Iniziato | Craig Hallum | Buy |
| 2024-11-14 | Iniziato | Rodman & Renshaw | Buy |
Eupraxia Pharmaceuticals Inc Borsa (EPRX) Ultime notizie
Is Eupraxia Pharmaceuticals Inc. stock oversold or undervaluedWeekly Trade Review & Verified Technical Signals - Newser
Will Eupraxia Pharmaceuticals Inc. (X43) stock outperform global peersJuly 2025 Setups & Consistent Growth Equity Picks - Newser
Analysts See More Than 77% Upside for Eupraxia Pharmaceuticals (EPRX), Here's Why - Finviz
Analysts See More Than 77% Upside for Eupraxia Pharmaceuticals (EPRX), Here’s Why - Yahoo Finance
(EPRX.WT.A) Comprehensive Trading Strategy Report - news.stocktradersdaily.com
Net current asset value per share of Eupraxia Pharmaceuticals, Inc. – LS:A3EGRS - TradingView
Is Eupraxia Pharmaceuticals Inc. stock a bargain at current levelsWeekly Trade Review & Long-Term Safe Investment Plans - Newser
Is Eupraxia Pharmaceuticals Inc. (X43) stock testing key supportJuly 2025 Sector Moves & Breakout Confirmation Alerts - Newser
How Eupraxia Pharmaceuticals Inc. (X43) stock correlates with oil markets2025 Institutional Moves & Weekly High Potential Alerts - Newser
How forex fluctuations impact Eupraxia Pharmaceuticals Inc. (X43) stockPortfolio Performance Report & Stock Market Timing Techniques - Newser
Is Eupraxia Pharmaceuticals Inc. (X43) stock expanding market penetration2025 Key Lessons & Low Risk High Win Rate Picks - Newser
(EPRX) Investment Analysis and Advice (EPRX:CA) - news.stocktradersdaily.com
Eupraxia Pharmaceuticals Inc. (EPRX.TO) stock price, news, quote and history - Yahoo Finance UK
Eupraxia Pharmaceuticals (EPRX) Stock Analysis Report | Financials & Insights - Benzinga
How Eupraxia Pharmaceuticals Inc. (X43) stock behaves under inflation pressureOptions Play & Daily Profit Focused Stock Screening - Newser
(EPRX.WT.A) Stock Market Analysis - news.stocktradersdaily.com
Scotia Capital Inc. Reduces Stake in Eupraxia Pharmaceuticals Inc. $EPRX - MarketBeat
(EPRX.WT.A) On The My Stocks Page - news.stocktradersdaily.com
Will Eupraxia Pharmaceuticals Inc. stock deliver better than expected guidanceChart Signals & Expert Approved Momentum Trade Ideas - BỘ NỘI VỤ
Paul Brennan Bought 60% More Shares In Eupraxia Pharmaceuticals - simplywall.st
Eupraxia Pharmaceuticals Appoints New CFO Amid Leadership Transition - MSN
Why Eupraxia Pharmaceuticals Inc. stock could benefit from AI revolutionTrade Analysis Report & AI Based Buy/Sell Signal Reports - BỘ NỘI VỤ
Will Eupraxia Pharmaceuticals Inc. stock reach Wall Street targetsMarket Sentiment Summary & Long-Term Growth Stock Strategies - BỘ NỘI VỤ
Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
(EPRX) Investment Analysis (EPRX:CA) - news.stocktradersdaily.com
(EPRX.WT.A) Long Term Investment Analysis - news.stocktradersdaily.com
(EPRX) Investment Report (EPRX:CA) - news.stocktradersdaily.com
Why Eupraxia Pharmaceuticals Inc. stock is favored by top institutionsWeekly Trend Summary & High Return Trade Opportunity Guides - newser.com
Bank of Montreal Can Has $215,000 Holdings in Eupraxia Pharmaceuticals Inc. $EPRX - Defense World
Is Eupraxia Pharmaceuticals Inc. (X43) stock supported by strong fundamentals2025 Market Overview & Real-Time Volume Analysis - newser.com
Eupraxia Pharmaceuticals Inc. stock trend forecastTrade Ideas & Fast Moving Market Watchlists - newser.com
How Eupraxia Pharmaceuticals Inc. (X43) stock compares with top peersMarket Rally & Risk Managed Investment Strategies - newser.com
Is Eupraxia Pharmaceuticals Inc. (X43) stock good for long term investingJuly 2025 Reactions & Weekly Hot Stock Watchlists - newser.com
(EPRX) Long Term Investment Analysis (EPRX:CA) - news.stocktradersdaily.com
Volatility clustering patterns for Eupraxia Pharmaceuticals Inc.July 2025 Intraday Action & Long-Term Safe Investment Plans - newser.com
Eupraxia Pharmaceuticals Inc Azioni (EPRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.10%
1.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):